Milton H. Grannatt
Direttore/Membro del Consiglio presso Myopharm Ltd.
Profilo
Milton H.
Grannatt is currently a Non-Executive Director at Myopharm Ltd.
He was previously an Outside Director at SymBio Pharmaceuticals Ltd.
Grannatt earned a doctorate degree from Lehigh University in 1975.
Posizioni attive di Milton H. Grannatt
| Società | Posizione | Inizio |
|---|---|---|
Myopharm Ltd.
 Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Milton H. Grannatt
| Società | Posizione | Fine |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | - |
Formazione di Milton H. Grannatt
| Lehigh University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Myopharm Ltd.
Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Health Technology |
- Borsa valori
- Insiders
- Milton H. Grannatt
